Virtual Press Conference: FDA Clears AGT to Begin Phase 1 Clinical Trial of HIV Cure Program
Learn about AGT's HIV Cure Program in 1-Hour
Date: Thursday August 13, 1pm EST
Live Online | Media Only
What Will I Learn?
AGT is excited to announce its clearance by the FDA to begin a Phase I Trial for an HIV cure. Sign-up for this virtual press conference to learn the details of its program from AGT's Leadership.
The theory and history behind the therapy - AGT103-T autologous cell therapy
What is know so far - Pre-clinical results and peer reviewed publications
Clinical and patient details - Clinical sites, enrollment plan, and timelines
What Is It For?
Reporters and media.